Charles River Laboratories International, Inc.
CRL Healthcare Diagnostics & Research
Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
Follow CRL
Charles River Laboratories International, Inc. (CRL) Operating margin
Charles River Laboratories International, Inc.'s operating margin over the twelve months to 30 June 2026 was 2.25%, up 1.6 percentage points from fiscal 2025 (0.63%). Over the past ten years it has ranged from 0.63% (fiscal 2025) to 16.7% (fiscal 2021) — the current reading is the lowest in ten years. That is above the Diagnostics & Research industry median of −8.57% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 0.63% | (4.98) |
| FY2024 | 5.61% | (9.34) |
| FY2023 | 15.0% | (1.42) |
| FY2022 | 16.4% | (0.29) |
| FY2021 | 16.7% | 1.86 |
| FY2020 | 14.8% | 1.40 |
| FY2019 | 13.4% | (1.22) |
| FY2018 | 14.6% | (0.90) |
| FY2017 | 15.5% | 1.39 |
| FY2016 | 14.1% | (1.01) |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 11.9% | (0.10) |
| Mar 2026 | 12.0% | 40.55 |
| Dec 2025 | −28.5% | (41.83) |
| Sep 2025 | 13.3% | 3.62 |
| 42 more quarters | Free account |
Against its own ten years
Operating margin against peers
| Company | Operating margin |
|---|---|
| QGEN QIAGEN N.V. compare | 21.2% |
| MEDP Medpace Holdings, Inc. compare | 21.0% |
| DGX Quest Diagnostics Incorporated compare | 14.1% |
| RVTY Revvity Inc. compare | 12.3% |
| LH Labcorp Holdings Inc. compare | 10.4% |
| ICLR ICON PLC compare | 3.57% |
| CRL Charles River Laboratories International, Inc. | 2.25% |
| TWST Twist Bioscience Corporation compare | −33.6% |
| GH Guardant Health, Inc. compare | −39.8% |
| Diagnostics & Research industry median | −8.57% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on CRL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement